β-Caryophyllene

$50

Only 1000 item(s) left in stock.

Products Details

Product Description

– β-Caryophyllene is a CB2 receptor agonist.

Web ID

– HY-N1415

Storage Temperature

– -20°C, 3 years; 4°C, 2 years (Powder)

Shipping

– Room Temperature

Applications

– Cancer-programmed cell death

Molecular Formula

– C15H24

References

– [1]de Oliveira CC, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016 Mar;56:26-31.|[2]Cheng Y, et al. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94(1-2):1-12.|[3]Dahham SS, et al. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllenefrom the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26;20(7):11808-29.

CAS Number

– 87-44-5

Molecular Weight

– 204.35

Compound Purity

– 99.12

SMILES

– C=C1CC/C=C(C)/CC[C@@]2([H])C(C)(C)C[C@]12[H]

Clinical Information

– No Development Reported

Research Area

– Cancer; Infection; Neurological Disease

Solubility

– DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)|Ethanol : ≥ 176.67 mg/mL|H2O : 0.67 mg/mL (ultrasonic)

Target

– Cannabinoid Receptor;Endogenous Metabolite

Isoform

– Human Endogenous Metabolite

Pathway

– GPCR/G Protein;Metabolic Enzyme/Protease;Neuronal Signaling

Product type

– Natural Products

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=